AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Amid wellness craze, FDA weighs lifting peptide restrictions